Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed) | RFA OD 22 025

Opportunity Information: Apply for RFA OD 22 025

The Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed) is a National Institutes of Health (NIH) grant opportunity meant to help promising postdoctoral researchers move more quickly from mentored training into stable, independent faculty careers while building a strong pipeline of investigators focused on tobacco regulatory science. The central goal is to support research that can directly inform how tobacco products are regulated, including evidence relevant to manufacturing standards, product distribution practices, and marketing approaches. In practical terms, the program is aimed at developing researchers who can generate policy-relevant data that regulators can use when designing, justifying, or evaluating rules intended to protect public health.

This award uses the K99/R00 "Pathway to Independence" structure, which is designed to bridge two career stages. The first phase (K99) supports a mentored postdoctoral period where the candidate builds a focused research program, strengthens skills needed for independence, and produces outputs that demonstrate readiness to compete as an independent investigator. The second phase (R00) supports the transition into a tenure-track or equivalent independent position, where the awardee launches an independent research program. The overall intent is not only to fund a research project, but also to support the candidate's career development, helping them establish a trajectory that leads to longer-term independence and competitiveness for future NIH or other research funding.

A key boundary in this specific opportunity is stated in the title: "Independent Clinical Trial Not Allowed." That means applicants should not propose an independent clinical trial as part of the research plan under this mechanism. While some studies involving humans may still be possible depending on NIH definitions and what is considered a clinical trial, the opportunity makes clear that applicants must design their work so it does not constitute an independent clinical trial under NIH policy. In other words, the research should be structured to fit tobacco regulatory research goals without crossing into a standalone clinical trial that the applicant would be responsible for running as the trial's primary sponsor or lead.

Eligibility for applicant organizations is broad across U.S.-based entities, spanning many sectors. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments (federally recognized) and other Native American tribal organizations; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (as long as they are not institutions of higher education in those categories); for-profit organizations other than small businesses; and small businesses. The announcement also explicitly highlights additional eligible applicant types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian serving institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), as well as faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. This emphasis signals an interest in broad participation and the inclusion of institutions that serve populations often underrepresented in biomedical research.

At the same time, there are strict limits related to foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply. In addition, non-domestic components of U.S. organizations are not eligible, and foreign components, as defined by the NIH Grants Policy Statement, are not allowed. The practical takeaway is that applications must be fully U.S.-based in terms of the applicant organization and project components, without foreign subcomponents that NIH would categorize as foreign components.

From an administrative standpoint, this is a discretionary grant opportunity offered by NIH, with the funding opportunity number RFA-OD-22-025 and CFDA number 93.077. The original closing date listed is March 12, 2025, and the opportunity was created on November 10, 2022. While the source data provided does not specify an award ceiling or the expected number of awards, the purpose statement makes clear that NIH is investing in people as much as projects: the program is structured to help highly qualified postdoctoral researchers with a research doctorate and/or clinical doctorate degree move into independent, tenure-track (or equivalent) roles while producing tobacco regulatory science that can support real-world regulatory decision-making.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.077.
• This funding opportunity was created on 2022-11-10.
• Applicants must submit their applications by 2025-03-12. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA OD 22 025

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: